411 related articles for article (PubMed ID: 32411128)
21. Putative Roles for Peptidylarginine Deiminases in COVID-19.
Arisan ED; Uysal-Onganer P; Lange S
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629995
[TBL] [Abstract][Full Text] [Related]
22. A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species.
Inal JM; Hristova M; Lange S
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955829
[TBL] [Abstract][Full Text] [Related]
23. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
24. Peptidylarginine Deiminase (PAD) and Post-Translational Protein Deimination-Novel Insights into Alveolata Metabolism, Epigenetic Regulation and Host-Pathogen Interactions.
Kristmundsson Á; Erlingsdóttir Á; Lange S
Biology (Basel); 2021 Feb; 10(3):. PubMed ID: 33653015
[TBL] [Abstract][Full Text] [Related]
25. The Extracellular Vesicle Citrullinome and Signature in a Piglet Model of Neonatal Seizures.
Mitra S; Harvey-Jones K; Kraev I; Verma V; Meehan C; Mintoft A; Norris G; Campbell E; Tucker K; Robertson NJ; Hristova M; Lange S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511288
[TBL] [Abstract][Full Text] [Related]
26. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
27. Post-translational protein deimination in cod (Gadus morhua L.) ontogeny novel roles in tissue remodelling and mucosal immune defences?
Magnadóttir B; Hayes P; Hristova M; Bragason BT; Nicholas AP; Dodds AW; Guðmundsdóttir S; Lange S
Dev Comp Immunol; 2018 Oct; 87():157-170. PubMed ID: 29908202
[TBL] [Abstract][Full Text] [Related]
28. Peptidylarginine deiminases and extracellular vesicles: prospective drug targets and biomarkers in central nervous system diseases and repair.
Lange S
Neural Regen Res; 2021 May; 16(5):934-938. PubMed ID: 33229732
[TBL] [Abstract][Full Text] [Related]
29. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
30. Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment.
Kosgodage US; Matewele P; Mastroianni G; Kraev I; Brotherton D; Awamaria B; Nicholas AP; Lange S; Inal JM
Front Cell Infect Microbiol; 2019; 9():227. PubMed ID: 31316918
[TBL] [Abstract][Full Text] [Related]
31. Peptidylarginine deiminases and deiminated proteins at the epidermal barrier.
Cau L; Méchin MC; Simon M
Exp Dermatol; 2018 Aug; 27(8):852-858. PubMed ID: 29756256
[TBL] [Abstract][Full Text] [Related]
32. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.
Méchin MC; Takahara H; Simon M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952341
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicle signatures and protein citrullination are modified in shore crabs (
Coates CJ; Kraev I; Rowley AF; Lange S
Virulence; 2023 Dec; 14(1):2180932. PubMed ID: 36813781
[TBL] [Abstract][Full Text] [Related]
34. Insights into peptidylarginine deiminase expression and citrullination pathways.
Yu K; Proost P
Trends Cell Biol; 2022 Sep; 32(9):746-761. PubMed ID: 35197210
[TBL] [Abstract][Full Text] [Related]
35. Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.
Lange S; Rocha-Ferreira E; Thei L; Mawjee P; Bennett K; Thompson PR; Subramanian V; Nicholas AP; Peebles D; Hristova M; Raivich G
J Neurochem; 2014 Aug; 130(4):555-62. PubMed ID: 24762056
[TBL] [Abstract][Full Text] [Related]
36. Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.
Yang ML; Sodré FMC; Mamula MJ; Overbergh L
Front Immunol; 2021; 12():678953. PubMed ID: 34140951
[TBL] [Abstract][Full Text] [Related]
37. Citrullination of matrisomal proteins in health and diseases.
Saifi MA; Ho IC
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220244. PubMed ID: 37778384
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive characterization of extracellular vesicles produced by environmental (Neff) and clinical (T4) strains of
Medeiros EG; Valente MR; Honorato L; Ferreira MdS; Mendoza SR; Gonçalves DdS; Martins Alcântara L; Gomes KX; Pinto MR; Nakayasu ES; Clair G; da Rocha IFM; Dos Reis FCG; Rodrigues ML; Alves LR; Nimrichter L; Casadevall A; Guimarães AJ
mSystems; 2024 Jun; 9(6):e0122623. PubMed ID: 38717186
[TBL] [Abstract][Full Text] [Related]
39. Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
Lange S; Gallagher M; Kholia S; Kosgodage US; Hristova M; Hardy J; Inal JM
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587234
[TBL] [Abstract][Full Text] [Related]
40. Deimination in epidermal barrier and hair formation.
Méchin MC; Simon M
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220245. PubMed ID: 37778378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
